Pathogen detection in infectious uveitis
Official title: Pathogen Detection in Infectious Uveitis in China
Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT04521673 · Data updated 2026-11-12
This study tests whether a broad set of lab methods can find infectious pathogens in the eyes of people with suspected infectious uveitis in China.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | February 26, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT04521673 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients at a referral eye clinic with clinically suspected infectious uveitis.
✕Probably not a fit
Patients with non-infectious uveitis or cases without detectable pathogens may not benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Infectious uveitis can lead to blindness, and some cases labeled idiopathic may actually harbor pathogens. This observational study uses multiple molecular techniques to detect infectious agents in ocular samples and to understand which pathogens are present in infectious uveitis in China. The goal is to map pathogen distribution and improve diagnostic insight using a broad diagnostic approach. No interventions are described, as the focus is on detection and characterization. Participants are patients with clinically suspected infectious uveitis seen at a referral eye clinic.
Why it matters
Potential benefit: If successful, the study could improve understanding of which pathogens cause infectious uveitis and guide future diagnostic strategies.
How similar studies have gone: Previous work has shown that broad molecular diagnostics can identify pathogens in ocular infections, supporting the approach as plausible but not yet established for this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient at a referal hospital eye clinic with clinically suspected infectious uveitis Exclusion Criteria: * Patients not eligible for the Inclusion Criteria * Confirmed auto-immune uveitis
Where it's running
-
Xinhua Hospital
Shanghai, China Recruiting
Study contacts
- Principal investigator: Ping Fei, MD，PhD — Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- Study coordinator: Ping Fei, MD,PhD
- Email: shirleypingfei@126.com
- Phone: 86-13636342098
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.